Cypress Bioscience, Inc. to Present at Jefferies 3rd Annual Healthcare Conference

* Reuters is not responsible for the content in this press release.

Tue Jun 16, 2009 6:30am EDT 

  SAN DIEGO, CA, Jun 16 (MARKET WIRE) -- 
Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina
Martucci Johnson, its Chief Operating Officer and Chief Financial
Officer, will present at the Jefferies 3rd Annual Healthcare Conference
on June 18, 2009.

    The Jefferies conference is being held in New York, NY. Ms. Johnson is
scheduled to present on Thursday, June 18th at 3:45 p.m. Eastern Time. The
audio broadcast of this presentation can be accessed at
http://www.wsw.com/webcast/jeff35/cypb/.

    A replay of the presentation will be available at the same web address as
well as on Cypress' website, http://www.cypressbio.com/events.php.

    About Cypress Bioscience

    Cypress Bioscience, Inc. provides therapeutics and personalized medicine
services, facilitating improved and individualized patient care. Cypress
addresses the evolving needs of specialist physicians and their patients
by identifying unmet medical needs in the areas of pain, rheumatology, and
physical medicine and rehabilitation, including challenging disorders such
as fibromyalgia and rheumatoid arthritis. This approach to improving
patient care creates a unique partnership with physicians. Current
products include Savella(TM) (milnacipran HCI) and the Avise PG(SM) and
Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for
rheumatoid arthritis.

    For more information about Cypress, please visit the Company's website at
www.cypressbio.com.

    

For additional information please contact

Mary Gieson
Investor Relations
(858) 452-2323
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.